The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 19-49

  Waldmann, T A ^a   Tagaya, Y ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmunity; IL 15 receptors; Interleukin 15; Lymphokine; mRNA translation; NK cell development

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR;

AUTOIMMUNITY; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFECTION; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; CELL DIFFERENTIATION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOTHERAPY; INFLAMMATION; INTERLEUKIN-15; KILLER CELLS, NATURAL; NEOPLASMS; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2; RETROVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION;

EID: 0033046593     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.19     Document Type: Review

References (143)

1. Bazan JF. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87:6934-38
2. Sato N, Miyajima A. 1994. Multimeric cytokine receptors:common versus specific functions. Curr. Opin. Cell Biol. 6: 174-79
3. Kishimoto T, Taga T, Akira S. 1994. Cytokine signal transduction. Cell 76:253-62
4. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K-I, Sugamura K. 1993. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874-77
5. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ. 1993. Interleukin 2 receptor γ chain:a functional component of the interleukin-7 receptor. Science 262:1877-80
6. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. 1994. A lymphokine, provisionally designated interleukin-T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4935-39
7. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. 1994. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 91:4940-44
8. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-68
9. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822-30
10. Waldmann TA, Tagaya Y, Bamford R. 1998. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 16:205-26
11. Tagaya Y, Bamford RN, DeFilippis A, Waldmann TA. 1996. IL-15:a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4:329-36
12. Kennedy MK, Park LS. 1996. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J. Clin. Immunol. 16:134-43
13. DiSanto JP. 1997. Cytokines:shared receptors, distinct functions. Curr. Biol. 7:R424-26
14. Bamford RN, Tagaya Y, Waldmann TA. 1997. Interleukin 15 - What it does and how it is controlled. Immunologist 5:52-56
15. Bamford RN, Battiata AP, Burton JD, Sharma H, Waldmann TA. 1996. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many up-stream AUGs that normally attenuate IL-15 mRNA translation, Proc. Natl. Acad. Sci. USA 93:2897-902
16. Bamford RN, DeFilippis AP, Azimi N, Kurys G, Waldmann TA. 1998. The 5′ UTR, signal peptide and 3′ coding sequences of IL-15 participate in its multifaceted translational control. J. Immunol. 160:4418-26
17. Fraser JD, Irving BA, Crabtree GR, Weiss A. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313-16
18. Lindstein T, June CH, Ledbetter JA, Stella G, Thompson CB. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339-43
19. Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, Orengo AM, Colombo MP, Azzarone B, Ferrini S. 1996. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12:2187-92
20. Onu A, Pohl T, Krause H, Bulfone-Paus S. 1997. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 158:255-62
21. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J. 14:3654-63
22. Tagaya Y, Burton JD, Miyamoto Y, Waldmann TA. 1996. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 15:4928-39
23. Trentin L, Zambello R, Facco M, Sancetta R, Agostini C, Semenzato G. 1997. Interleukin-15:a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk. Lymph. 27:35-42
24. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. 1995. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 154:483-90
25. Wilkinson PC, Liew FY. 1995. Chemoattraction of human blood T lymphocytes by interleukin-15. J. Exp. Med. 181:1255-59
26. Carson WE, Giri JG, Lindermann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-403
27. Suzuki H, Duncan GS, Takimoto H, Mak TW. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185:499-505
28. + hematopoietic progenitor cells. Blood 87:2632-40
29. c transduced severe combined immunodeficiency Xl bone marrow cells. Blood 88:3901-9
30. Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L. 1997. Interleukin-15 induced maturation of human natural killer cells from early thymic precursors, selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27:1374-80
31. Flamand L, Stefanescu I, Menezes J. 1996. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 97:1373-81
32. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K, Caligiuri MA. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin Invest. 96:2578-82
33. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai C-F, Croce CM, Baumann H, Caligiuri MA. 1997. Potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 99:937-43
34. + cell development. J. Immunol. 159:5931-35
35. Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda Y, Waldmann TA, Taniguchi T, Taki S. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700-3
36. +T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 187:967-72
37. Leclercq G, Debacker V, De Smedt M, Plum J. 1996. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 184:325-36
38. Puzanov IJ, Williams NS, Schatzle J, Sivakumar PV, Bennet M, Kumar V. 1997. Ontogeny of NK cells and the bone marrow microenvironment:Where does IL15 fit in? Res. Immunol. 148:195-201
39. Atedzoe BN, Ahmad A, Menezes J. 1997. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol. 159:4966-72
40. Quinn LS, Haugk KL, Grabstein KH. 1995. Interleukin-15:a novel anabolic cytokine for skeletal muscle. Endocrinology 136:3669-72
41. Quinn LS, Haugk KL, Damon SE. 1997. Interleukin-15 stimulates C2 skeletal myoblast differentiation. Biochem. Biophys. Res. Commun. 239:6-10
42. McInnes IB, Al-Mughales J, Field M, Leung BP, Huang F-P, Dixon R, Sturrock RD, Wilkinson PC, Liew FY. 1996. The role of interleukin 15 in T-cell migration and activation in rheumatoid arthritis. Nature Med. 2:175-82
43. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. 1997. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nature Med. 3:189-95
44. Reinecker HC, MacDermott RP, Mirau S, Dignass A, Podolsky DK. 1996. Intestinal epithelial cells both express and respond to interleukin-15. Gastroenterology 111:1706-13
45. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. 1998. Human T cell lymphotropic virus type I tax protein trans-activates interleukin 15 gene transcription through an NF-κ B site. Proc. Natl. Acad. Sci. USA 95:2452-57
46. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY. 1998. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis:a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 160:5654-60
47. Pilson RS, Levin W, Desai B, Reik LM, Lin P, Korkmaz-Duffy E, Campbell E, Tso JY, Kerwin JA, Hakimi J. 1997. Bispecific humanized anti-IL-2 receptor αβ antibodies inhibitory for both IL-2-and IL-15-mediated proliferation. J. Immunol. 159:1543-56
48. 389 sIL-15. Protein Eng. 8:1317-21
49. Canals A, Grimm DR, Gasbarre LC, Lunney JK, Zarlenga DS. 1997. Molecular cloning of cDNA encoding porcine interleukin-15. Gene 195:337-39
50. Anderson DM, Johnson L, Glaccum MB, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Kirstein MN, Shapiro DN, Morris SW, Grabstein K, Cosman D. 1995. Chromosomal assignment and genomic structure of IL-15. Genomics 25:701-6
51. Seigel LJ, Harper ME, Wong-Staal F, Gallo RC, Nash WG, O'Brien SJ. 1984. Gene for T-cell growth factor:location on human chromosome 4q and feline chromosome BI. Science 223:175-78
52. Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover JA, Bamford RN, Waldmann TA. 1997. Generation of secretable and non-secretable intcrleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA 94:14444-49
53. Doherty TM, Seder RA, Sher A. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735-41
54. Mody CH, Spurrell JCL, Wood CJ. 1998. Interleukin 15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes. J. Infect. Dis. 178:803-14
55. Nishimura H, Hiromatsu K, Kobayashi N, Grabstein KH, Paxton R, Sugamura K, Bluestone JA, Yoshikai Y. 1996. IL-15 is a novel growth factor for murine γδ T cells induced by Salmonella infection. J. Immunol. 156:663-69
56. Vázquez N, Walsh TJ, Friedman D, Chanock SJ, Lyman CA. 1998. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun. 66:145-50
57. Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL. 1997. IL-15, an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158:800-6
58. Washizu J, Nishimura H, Nakamura N, Nimura Y, Yoshikai Y. 1998. The NF-kappa B binding site is essential for translational activation of the IL-15 gene. Immunogenetics 48:1-7
59. Kozak M. 1987. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-48
60. Kozak M. 1991. An analysis of vertebrate mRNA sequences:intimations of translational control. J. Cell Biol. 115:887-903
61. Kozak M. 1992. A consideration of alternative models for the initiation of translation in eukaryotes. Crit. Rev. Biochem. Mol. Biol. 27:385-402
62. Weinberg AD, Swain SL. 1990. IL-2 receptor (Tac antigen) protein expression is down-regulated by the 5′-untranslated region of the mRNA. J. Immunol. 144: 4712-20
63. Arrick BA, Lee AL, Grendell RL, Derynck R. 1991. Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5′ untranslated region. Mol. Cell. Biol. 11:4306-13
64. Bates B, Hardin J, Zhan X, Drickamer K, Goldfarb M. 1991. Biosynthesis of human fibroblast growth factor-5. Mol. Cell. Biol. 11:1840-45
65. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, Mosley B, March CJ, Urdal D, Gillis S, Cosman D, Goodwin RG. 1988. Stimulation of B-cell progenitors by cloned murinc interleukin-7. Nature 333:571-73
66. McBratney S, Chen CY, Sarnow P. 1993. Internal initiation of translation. Curr. Opin. Cell. Biol. 5:961-65
67. Belsham GJ, Sonenberg N, Svitkin YV. 1995. The role of the La autoantigen in internal initiation. Curr. Top. Microbiol. Immunol. 203:85-98
68. Macejak DG, Sarnow P. 1991. Internal initiation of translation mediated by the 5′ leader of a cellular mRNA. Nature 353:90-94
69. Yueh A, Schneider RJ. 1996. Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev. 10:1557-67
70. Nishimura H, Washizu J, Nakamura N, Enomoto A, Yoshikai Y. 1998. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J. Immunol. 160:936-42
71. Hentze MW, Rouault TA, Caughman SW, Dancis W, Harford JB, Klausner RD. 1987. A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron. Proc. Natl. Acad. Sci. USA 84:6730-34
72. Chu E, Voellcr D, Koeller DM, Drake JC, Takimoto CH, Maley GF, Maley F, Allegra CJ. 1993. Identification of an RNA binding site for human thymidylate synthase. Proc. Natl. Acad. Sci. USA 90:517-21
73. Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:4442-49
74. Theodorakis NG, Barerji SS, Morimoto RI. 1988. HSP70 mRNA translation in chicken reticulocytes is regulated at the level of elongation. J. Biol. Chem. 263:14579-85
75. Kaspar RL, Gehrke L. 1994. Peripheral blood mononuclear cells stimulated with C5a or lipopolysaccharide to synthesize equivalent levels of IL-1β mRNA show unequal IL-1β protein accumulation but similar polyribosome profiles. J. Immunol. 153:277-86
76. Welsh M, Scherberg N, Gilmore R, Steiner DF. 1986. Translational control of insulin biosynthesis. Evidence for regulation of elongation, initiation and signal recognition-particle-mediated translation arrest by glucose. Biochem. J. 235:459-67
77. d mutant. Cell 64:1025-35
78. Acland P, Dixon M, Peters G, Dickson C. 1990. Subcellular fate of the Int-2 onco-protein is determined by choice of initiation codon. Nature 343:662-65
79. Hatakeyama M, Tsudo M, Minamoto S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T. 1989. Interleukin-2 receptor β chain gene:generation of three receptor forms by cloned human α and β chain cDNAs. Science 244:551-56
80. Goldsmith MA, Greene WC. 1994. Interleukin-2 and the interleukin-2 receptor. In The Cytokine Handbook, ed. AW Thomson, pp. 57-80. London:Academic. 2nd ed.
81. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K. 1992. Cloning of the γ chain of the human IL-2 receptor. Science 257:379-82
82. Anderson DM, Kumaki S, Abdieh M, Bertles J, Tometsko M, Loomis A, Giri J, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Shapiro DN, Morris SW, Park LS, Cosman D. 1995. Functional characterization of human interleukin 15 receptor α chain and close linkage of IL-15RA and IL-2RA genes. J. Biol. Chem. 270:29862-69
83. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN. 1994. Involvement of the Jak-3 Janus kinase in signaling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153-57
84. Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, O'Shea JJ. 1995. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukin 2 and 15. Proc. Natl. Acad. Sci. USA 92:8705-9
85. Lin J-X, Migone T-S, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-39
86. Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, Taniguchi T. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and Ick cooperate in hematopoietic cell proliferation. Cell 81:223-31
87. + T cells in vivo by IL-15. Immunity 8:591-99
88. Carson WE, Caligiuri MA. 1996. Interleukin 15:a potential player during the innate immune response to infection. Exp. Parasitol. 84:291-94
89. Inagaki-Ohara K, Nishimura H, Mitani A, Yoshikai Y. 1997. Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing γδ T cell receptor in mice. Eur. J. Immunol. 27:2885-91
90. Garcia VE, Jullien D, Song M, Uyemura K, Shuai K, Morita CT, Modlin RL. 1998. IL-15 enhances the response of human γδ T cells to nonpeptide microbial antigens. J. Immunol. 160:4322-29
91. c-chains of the IL-2 receptor. J. Invest. Dermatol. 105:837-43
92. Jonuleit H, Wiedemann K, Muller G, Degwert J, Hoppe U, Knop J, Enk AH. 1997. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells. J. Immunol. 158:2610-15
93. Blauvelt A, Asada H, Klaus-Kovtun V, Altman DJ, Lucey DR, Katz SI. 1996. Interleukin-15 mRNA is expressed by human keratinocytes, Langerhans cells, and blood-derived dendritic cells and is down-regulated by ultraviolet B radiation. J. Invest. Dermatol. 106:1047-52
94. Patki AH, Quinones-Mateu ME, Dorazio D, Yen-Lieberman B, Boom WH, Thomas EK, Lederman MM. 1996. Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression. J. Clin. Invest. 98:616-21
95. Lewko WM, Smith TL, Bowman DJ, Good RW, Oldham RK. 1995. Interleukin-15 and the growth of tumor derived activated T-cells. Cancer Biother. 10:13-20
96. Seder RA. 1995. IL-2 and IL-15 induce a TH 1 response from naive CD4+ transgenic T cells following short term in vitro stimulation. In Progr. Immunol. 9th Int. Congr. Immunol., San Francisco, p. 75
97. + T cells for IFN-γ but have differential effects on priming for IL-4. J. Immunol. 156:2413-22
98. Ye W, Young JD, Liu, C-C. 1996. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. Cell. Immunol. 174:54-62
99. Treiber-Held S, Stewart DM, Kurman CC, Nelson DL. 1996. IL-15 induces the release of soluble IL-2Rα from human peripheral blood mononuclear cells. Clin. Immunol. Immunopathol. 79:71-78
100. Treiber-Held S, Stewart DM, Barraclough HA, Kurman CC, Nelson DL. 1996. Release of sIL-2Rα from and activation of native human peripheral blood mononuclear cells by recombinant IL-15. Clin. Immunol. Immunopathol. 80:67-75
101. Bulfone-Paus S, Dörkop II, Paus R, Krause, H, Pohl T, Onu A. 1997. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 9:507-13
102. Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, Krause H, Kunzendorf U. 1997. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 3:1124-28
103. Kaneganc H, Tosato G. 1996. Activation or naive and memory T cells by interleukin-15. Blood 88:230-35
104. Salvucci O, Mami-Chouaib F, Moreau JL, Theze J, Chehimi J, Chouaib S. 1996. Differential regulation of interleukin-12-and interleukin-15-induced natural killer cell activation by interleukin-4. Eur. J. Immunol. 26:2736-41
105. Damjanovich S, Bene L, Matko J, Alileche A, Goldman CK, Sharrow S, Waldmann TA. 1997. Preassembly of interleukin 2 (IL-2) receptor subunits on resting Kit 225 K6 T cells and their modulation by IL-2, IL-7, and IL-15:a fluorescence resonance energy transfer study. Proc. Natl. Acad. Sci. USA 94:13134 39
106. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, Paul WE, Katz SI, Love PE, Leonard WJ. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2:223-38
107. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky K. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA 92:377-81
108. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059-61
109. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Nogouchi M, Markert NL, Buckley RH, O'Shea JJ, Leonard WJ. 1995. Mutation of Jak3 in a patient with SCID:essential role of Jak3 in lymphoid development. Science 270:797-800
110. Macchi P, Villa A, Gillani S, Sacco MG, Frattini A, Porta F, Vgazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo LD. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immunodeficiency disease (SCID). Nature 377:65-68
111. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. New Engl. J. Med. 320:1731-35
112. Badolato R, Ponzi AN, Millesimo M, Notarangelo LD, Musso T. 1997. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90:2804-9
113. Angiolillo AL, Kanegane H, Sgadari C, Reaman GH, Tosato G. 1997. Interleukin-15 promotes angiogenesis in vivo. Biochem. Biophys. Res. Commun. 233:231-37
114. Lee YB, Satoh, J, Walker DG, Kim SU. 1996. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 7:1062-66
115. Hanisch U-K, Lyons SA, Prinz M, Nolte C, Weber JR, Kettenmann H, Kirchhoff F. 1997. Mouse brain microglia express interleukin-15 and its multimeric recepior complex functionally coupled to Janus kinase activity. J. Biol. Chem. 272:28853-60
116. Stevens AC, Matthews J, Andres P, Baffis V, Zheng XX, Chae D-W, Smith J, Strom TB, Maslinski W. 1997. Interleukin-15 signals T84 colonie epithelial cells in the absence of the interleukin-2 receptor β-chain. Am. J. Physiol. 272:G1201-8
117. Feldmann M, Brennan FM, Maini RN. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397-440
118. Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE. 1998. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest. 101:1261-72
119. Kirman I, Nielsen OH. 1996. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91:1789-94
120. Kakumu S, Okumura A, IshikawaT, Yano M, hnomoto A, Nishimura H, Yoshioka K, Yoshikai Y. 1997. Serum levels of IL-10, IL-I5 and soluble tumour necrosis factor-alpha (TNF-α) receptors in type C chronic liver disease. Clin. Exp. Immunol 109:458-63
121. Agostini C, Trenlin L, Facco M, Sancetta R, Cerutti A, Tassinari C, Cimarosto L, Adami F, Cipriani A, Zambello R, Semenzato G. 1996. Role of IL-15, IL-2 and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 157:910-18
122. Kivisakk P, Matusevicius D, He B, Soderstrom M, Fredrikson S, Link H. 1998. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 111:193-97
123. Yodoi J, Takatsuki K, Masuda T. 1974. Two cases of T-cell chronic lymphotropic leukemia in Japan. New Engl. J. Med. 290:572-73
124. Jacobson S, Zaninovic V, Mora O, Rodgers-Johnson P, Sheremata WA, Gibbs CJ Jr, Gajdusek C, McFarlin DE. 1988. Immunological findings in neurological diseases associated with antibodies to HTLV-I:activated lymphocytes in tropical spastic paraparesis. Ann Neurol 23:196s-200s (Suppl.)
125. Tendler CL, Greenberg SJ, Blattner WA, Manns A, Murphy E, Heisher T, Hanchard B, Morgan O, Burton JD, Nelson DL, Waldmann TA. 1990. Transactivation of interleukin-2 and its receptor induces immune activation in HTLV-I associated myelopathy:pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA 87:5218-22
126. Yamada Y, Sugawara K, Hata T, Tsuruta K, Moriuchi R, Maeda T, Atogami S, Murata K, Fujimoto K, Kohno T, Tsukasaki K, Tomonaga M, Hirakata Y, Kamihira S. 1998. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines:expression of IL-15 receptor α on ATL cells. Blood 91:4265-72
127. Migone TS, Lin JX, Cereseto A, Muiloy JC, O'Shea JJ, Franchini G, Leonard WL. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269:79-81
128. Xu X, Kang SH, Heidenreich O, Okerholm M, O'Shea JJ, Nerenberg MI. 1995. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-I) tax protein or virus-transformed cells. J. Clin. Invest. 96:1548-55
129. Kacani L, Stoiber H, Dierich MP. 1997. Role of IL-15 in HIV-1-associated hypergammaglobulinemia. Clin. Exp. Immunol. 108:14-18
130. Chehimi J, Marshall JD, Salvucci O, Frank I, Chehimi S, Kawecki S, Bacheller D, Rifat S, Chouaib S. 1997. IL-15 enhances immune functions during HTV infection. J. Immunol. 158:5978-87
131. Barzegar C, Meazza R, Pereno R, PottinClemenceau C, Scudeletti M, Brouty-Boye D, Doucet C, Taoufik Y, Ritz J, Musselli C, Mishal Z, Jasmin C, Indiveri F, Ferrini S, Azzarone B. 1998. IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops. Oncogene 16:2503-12
132. Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, Perin A, Milani A, Pizzolo G, Rodeghiero F, Agostini C, Meazza R, Ferrini S, Semenzato G. 1997. Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 89: 201-11
133. Pavlakis M, Strehlau J, Lipman M, Shapiro M, Maslinski W, Strom TB. 1996. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 62:543-45
134. Manfro RC, Roy-Chaudhury P, Zheng XX, Steiger J, Nickerson PW, Li Y, Maslinski W, Strom TB. 1997. Interleukin-15 gene transcripts arc present in rejecting islet allografts. Transplantation Proc. 29:1077-78
135. γ2a protein blocks delayed-type hypersensitivity. J. Immunol. 160:5742-48
136. Waldmann TA. 1993. The IL-2/IL-2 receptor system:a target for rational immune intervention. Immunol. Today 14: 264-70
137. Waldmann TA, White JD, Goldman CK, Top L, Grant A, Bamford R, Roessler E, Horak ID, Zaknocn S, Kasten-Sportès C, England R, Horak E, Mishra B, Dipre M, Hale P, Fleisher TA, Junghans RP, Jaffe ES, Nelson DL. 1993. The interleukin-2 receptor:a target for monoclonal antibody treatment of human T-cell lymphotropic virus I-induced adult T-cell leukemia. Blood 82:1701-12
138. Waldmann TA, White JD, Carrasquillo JA, Reynolds JC, Paik CH, Gansow OA, Brechbiel MW, Jaffe ES, Fleisher TA, Goldman CK, Top L, Bamford RN, Zaknocn S, Roessler E, Kasten-Sportès C, England R, Litou H, Johnson JA, Jackson-White T, Manns A, Hanchard B, Junghans RP, Nelson DL. 1995. Radioimmunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac, Blood 86:4063-75
139. Vincenti F, Kirkman R, Light S, Bumgardner G, Pescovitz M, Halloran P, Neylan J, Wilkinson A, Ekberg H, Gaston R, Backman L, Burdick J. 1998. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. New Engl. J. Med. 338:161-65
140. Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M, Bacher JD, Kasten-Sportès C, Martinucci JL, Goldman CK, Clark RE, Waldmann TA. 1994. Humanized antibody directed to the IL-2 receptor β chain prolongs primate cardiac allograft survival. J. Immunol. 153:4330-38
141. Tsudo M, Goldman CK, Bongiovanni KF, Chan WC, Winton EF, Yagita M, Grim EA, Waldmann TA. 1987. The P75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc. Natl. Acad. Sci. USA 84:5394-98
142. Yoon HJ, Sugamura K, Loughran TP Jr. 1990. Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor. Leukemia 4:848-50
143. Annu. Rev. Immunol. 1999. 17:51-88